Wednesday, 28 May 2025

C1240468

 A

"ITP with nephritis" is a clinical scenario where two distinct conditions are present:


1. Immune Thrombocytopenic Purpura (ITP):

  • An autoimmune disorder where the immune system attacks and destroys platelets.

  • Leads to thrombocytopenia (low platelet count) and increased bleeding risk.

2. Nephritis:

  • Refers to inflammation of the kidneys, which can manifest as:

    • Hematuria (blood in urine)

    • Proteinuria (protein in urine)

    • Elevated creatinine

    • Edema and hypertension in some cases


Clinical Significance of ITP with Nephritis:

This combination is unusual and often points toward an underlying systemic autoimmune disease, most commonly:

Systemic Lupus Erythematosus (SLE):

  • Common link between ITP and nephritis.

  • Can present with both immune-mediated thrombocytopenia and lupus nephritis.

  • Additional features: ANA positive, anti-dsDNA, low complement levels (C3, C4), rash, arthritis, etc.

Other possible differentials:

  • Antiphospholipid Syndrome (APS) – especially if thrombosis is involved.

  • Vasculitides (e.g., ANCA-associated)

  • Drug-induced (e.g., certain medications can cause both thrombocytopenia and interstitial nephritis)

  • Infections (e.g., hepatitis C, HIV, EBV)


Investigations to Consider:

  • Full blood count and blood film

  • Renal function tests and urinalysis

  • Autoimmune panel: ANA, dsDNA, ENA, complements

  • Hepatitis and HIV serology

  • Renal biopsy (if indicated) – for exact classification of nephritis


Management Overview:

Depends on the underlying cause, severity, and organ involvement:

  • Steroids are often first-line for both ITP and nephritis (especially in lupus)

  • Immunosuppressants: Mycophenolate, cyclophosphamide, rituximab, depending on severity

  • IVIG or platelet transfusions for severe ITP

  • ACE inhibitors or ARBs for proteinuria

  • Close monitoring of renal function, proteinuria, and platelet counts


If you have more specific clinical context (age, underlying disease, test results), I can tailor the explanation and management approach further.

No comments:

Post a Comment